SCHEMBL1280184

SCHEMBL1280184

FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 1.00
KMT2A Q03164 1/20 1.00
TDP1 Q9NUW8 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perflunafene SCHEMBL1069193 1.00 MEN1 (1.00) MEN1KMT2ATDP1
SCHEMBL1279184 1.00 MEN1 (1.00) MEN1KMT2ATDP1
Perflunafene SCHEMBL4418110 1.00 MEN1 (1.00) MEN1KMT2ATDP1
SCHEMBL15755574 1.00 MEN1 (1.00) MEN1KMT2ATDP1
SCHEMBL10889508 1.00 MEN1 (1.00) MEN1KMT2ATDP1
Perflunafene SCHEMBL63605 1.00 MEN1 (1.00) MEN1KMT2ATDP1
SCHEMBL2476658 1.00 MEN1 (1.00) MEN1KMT2ATDP1
Perflunafene SCHEMBL63606 1.00 MEN1 (1.00) MEN1KMT2ATDP1
SCHEMBL18979331 0.94 MEN1 (0.89) MEN1KMT2ATDP1
SCHEMBL1771191 0.94 MEN1 (0.89) MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8753606-B2 Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-06-17 US claimed
US-8734762-B2 Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-05-27 US claimed
US-8697389-B2 Cell labeling and imaging using multifunctional perfluorocarbon nanoemulsion KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-04-15 US claimed
US-20120088261-A1 CELL LABELING AND IMAGING USING MULTIFUNCTIONAL PERFLUOROCARBON NANOEMULSION KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-12 US claimed
US-20110110867-A1 MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2011-05-12 US claimed
US-20100233094-A1 PERFLUOROCARBON NANO-EMULSION CONTAINING QUANTUM DOT NANOPARTICLES AND METHOD FOR PREPARING THE SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) 2010-09-16 US claimed
WO-2009154425-A9 MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2010-03-18 WO claimed
WO-2009154425-A2 MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-12-23 WO claimed
US-4586511-A Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1986-05-06 US claimed
US-4558279-A Methods for detecting and imaging a temperature of an object by nuclear magnetic resonance UNIVERSITY OF CINCINNATI (US) 1985-12-10 US claimed
US-12509987-B2 Continuous characterization and communication of chemical tracer Patina IP LLC (US) 2025-12-30 US disclosed
US-20240307364-A1 GAS TRANSMISSION EMULSION FOR INTRAVENOUS ADMINISTRATION ARSHINTSEVA ELENA VALENTINOVNA (RU) 2024-09-19 US disclosed
WO-2024058815-A1 CONTINUOUS CHARACTERIZATION AND COMMUNICATION OF CHEMICAL TRACER Patina IP LLC (US) 2024-03-21 WO disclosed
US-20230296018-A1 CONTINUOUS CHARACTERIZATION AND COMMUNICATION OF CHEMICAL TRACER Patina LLC (US) 2023-09-21 US disclosed
EP-3334801-B1 MATERIAL COMBINATION MERCK PATENT GMBH (DE) 2020-05-27 EP disclosed
WO-1983003201-A1 METHODS OF TREATING THE EYE WITH LIQUID PERFLUOROCARBONS CHILDRENS HOSP MEDICAL CENTER (US) 1983-09-29 WO disclosed
EP-0089815-A1 Liquid perfluorocarbons, for use in ocular therapy, and preparations containing them Haidt, Sterling Joel (US) 1983-09-28 EP disclosed
EP-0089232-A2 Perfluorocarbon liquids useful in eye treatment and diagnostic procedures CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1983-09-21 EP disclosed
WO-1983002885-A1 METHOD FOR PROVIDING AN OXYGEN BEARING LIQUID TO A BLOOD VESSEL FOR THE PERFORMANCE OF A MEDICAL PROCEDURE LOEB, MARVIN, P. 1983-09-01 WO disclosed
US-4289499-A BY DETERMINATION OF CRITICAL SOLUTION TEMPERATURE CHILDRENS HOSPITAL MEDICAL CENTER (US) 1981-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509987-B2 Continuous characterization and communication of chemical tracer EXOSC10, CD69, FABP3 MEN1 1892/4885KMT2A 4149/4885TDP1 4074/4885
US-20240307364-A1 GAS TRANSMISSION EMULSION FOR INTRAVENOUS ADMINISTRATION PAOX, SLCO4C1, SLCO2A1 MEN1 4474/4885KMT2A 4446/4885TDP1 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.